» Authors » Adam Nopora

Adam Nopora

Explore the profile of Adam Nopora including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 584
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Weidle U, Nopora A
Cancer Genomics Proteomics . 2024 Jun; 21(4):327-349. PMID: 38944427
We have reviewed the literature for circular RNAs (circRNAs) with efficacy in preclinical pancreatic-cancer related in vivo models. The identified circRNAs target chemoresistance mechanisms (n=5), secreted proteins and transmembrane receptors...
2.
Nopora A, Weidle U
Cancer Genomics Proteomics . 2024 Feb; 21(2):118-136. PMID: 38423599
Acute myeloid leukemia (AML) is a genetically extremely heterogeneous disease. Drug resistance after induction therapy is a very frequent event resulting in poor medium survival times. Therefore, the identification of...
3.
Weidle U, Nopora A
Cancer Genomics Proteomics . 2023 Oct; 20(6):500-521. PMID: 37889063
Hepatocellular carcinoma (HCC) ranges as number two with respect to the incidence of tumors and is associated with a dismal prognosis. The therapeutic efficacy of approved multi-tyrosine kinase inhibitors and...
4.
Weidle U, Nopora A
Cancer Genomics Proteomics . 2023 Mar; 20(2):132-153. PMID: 36870691
Patients with disseminated colorectal cancer have a dismal prognosis with a 5-year survival rate of only 13%. In order to identify new treatment modalities and new targets, we searched the...
5.
Weidle U, Nopora A
Anticancer Res . 2022 Jul; 42(7):3233-3249. PMID: 35790246
Esophageal cancer is of two subtypes: Esophageal adenocarcinoma and esophageal squamous cell carcinoma (ESCC). Both are associated with a dismal prognosis. Therefore, the identification of new targets and treatment modalities...
6.
Weidle U, Nopora A
Cancer Genomics Proteomics . 2022 Feb; 19(2):113-129. PMID: 35181582
Squamous cell carcinoma of the esophagus is associated with a dismal prognosis. Therefore, identification of new targets and implementation of new treatment modalities are issues of paramount importance. Based on...
7.
Weidle U, Nopora A
Cancer Genomics Proteomics . 2021 Sep; 18(5):591-603. PMID: 34479913
Small-cell lung cancer, a neuro-endocrine type of lung cancers, responds very well to chemotherapy-based agents. However, a high frequency of relapse due to adaptive resistance is observed. Immunotherapy-based treatments with...
8.
Weidle U, Nopora A
Cancer Genomics Proteomics . 2021 May; 18(3 Suppl):349-368. PMID: 33994361
In order to identify new targets and treatment modalities for clear cell renal carcinoma, we surveyed the literature with respect to microRNAs involved in this disease. In this review, we...
9.
Weidle U, Birzele F, Nopora A
Cancer Genomics Proteomics . 2021 Jan; 18(1):1-15. PMID: 33419892
The annual death toll for gastric cancer is in the range of 700,000 worldwide. Even in patients with early-stage gastric cancer recurrence within five years has been observed after surgical...
10.
Weidle U, Nopora A
Cancer Genomics Proteomics . 2020 Jun; 17(4):321-334. PMID: 32576578
Background/aim: Multiple myeloma is a B-cell neoplasm, which can spread within the marrow of the bones forming many small tumors. In advanced disease, multiple myeloma can spread to the blood...